Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus

Psychopharmacology

Volumn 148, Issue 3, 2000, Pages 281-288

  Morita, Takuma ^a   Sonoda, Rie ^a   Nakato, Kazuhiro ^a   Koshiya, Kazuo ^b   Wanibuchi, Fumikazu ^a   Yamaguchi, Tokio ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b Yamanouchi USA Inc   (United States)

Author keywords

Hole board apparatus; Methamphetamine; NMDA; Phencyclidine; Schizophrenia

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; CLOZAPINE; DEXTRO ALANINE; DIZOCILPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; RISPERIDONE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXPLORATORY BEHAVIOR; INHIBITION KINETICS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; TASK PERFORMANCE;

EID: 0034098442     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050052     Document Type: Article

References (38)

1. Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. Am J Psychiatry 135:1081-1084
2. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anesthetics, ketamine and phencyclidine reduce excitation of central mammalian neurons by N-methyl-aspartate. Br J Pharmacol 79:565-575
3. Balster RL (1987) The behavioral pharmacology of phencyclidine. In: Meltzer HY (eds) Psychopharmacology (the third generation of progress). Raven Press, New York, pp 1573-1579
4. Bertolino M, Vicini S, Mazzetta J, Costa E (1988) Phencyclidine and glycine modulate NMDA-activated high conductance cationic channels by acting at different sites. Neurosci Lett 84:351-355
5. Carpenter WT Jr (1996) The treatment of negative symptoms: Pharmacological and methodological issues. Br J Psychiatry 168:9-16
6. Coan EJ, Collingridge GL (1987) Effects of phencyclidine, SKF10,047 and related psychotomimetic agents on N-methyl-D-aspartate receptor mediated synaptic responses in rat hippocampal slices. Br J Pharmacol 91:547-565
7. Contreras CP (1990) D-Serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology 29:291-293
8. 3H]D-AP-5 binding sites on brain membranes and anticonvulsant activity. Brain Res 382:169-173
9. Deutsch SI, Mastropaolo J, Schwartz BL, Rosse RB, Morihisa JM (1989) A "glutamatergic hypothesis" of schizophrenia. Clin Neuropharmacol 12:1-13
10. Geyer MA, Light RK, Rose GJ, Peterson LR, Hornet DD, Adams LM, Hawking RL (1979) A characteristic effect of hallucinogens on investigatory responding in rats. Psychopharmacology 65:35-40
11. Hertzman M, Reba RC, Kotlyarov EV (1990) Single photon emission computed tomography in phencyclidine and related drug abuse. Am J Psychiatry 147:255-256
12. Javitt DC (1987) Negative schizophrenic synptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry 9:12-35
13. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
14. Javitt DC, Sershen S, Hashim A, Lajtha A (1997) Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide. Neuropsychopharmacology 17:202-204
15. Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in culture mouse brain neurons. Nature 325:529-531
16. Kemp JA, Leeson PD (1993) The glycine site of the NMDA receptor - five years on. Trends Pharmacol Sci 14:20-25
17. Kish GB (1970) Reduced cognitive innovation and stimulus-seeking in chronic schizophrenia. J Clinical Psychiatry 26:170-174
18. Koek W, Woods JH, Rice KC, Jacobson AE, Huguenin PN, Burke TR Jr (1984) Phencyclidine-induced catalepsy in pigeons: specificity and stereoselectivity. Eur J Pharmacol 106:635-638
19. Ljungberg T, Ungerstedt U (1976) Automatic registration of behavior related to dopamine and noradrenaline transmission. Eur J Pharmacol 36:181-188
20. Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11:81-86
21. Löscher W, Annis R, Hönack D (1993) Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioral effects in rats. Eur J Pharmacol 242:263-274
22. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizophrenimimetic drug - Sernyl. Arch J Neurol Psychiatry 81:363-369
23. Makanjuola ROA, Hill G, Maben I, Dow RC, Ashcroft GW (1977) An automated method for studying exploratory and stereotyped behavior in rats. Psychopharmacology 52:271-277
24. Masten VDL, Geyer MA (1991) Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats. Neuropharmacology 30:629-636
25. Meise U, Fleischhacker WW (1996) Perspective treatment needs in schizophrenia. Br J Psychiatry 168:9-16
26. Nakajima M, Inui A, Miura M, Hirosue Y, Okita M, Himori N, Baba S, Kasuga M (1994) Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice. J Pharmacol Exp Ther 268:1010-1014
27. Nishijima K, Kashiwa A, Hashimoto A, Iwama H, Umino A, Nishikawa A (1996) Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse 22:304-312
28. 22Na flux from rat hippocampal slices by phencyclidine and other drugs. Neuropharmacology 27:493-497
29. Seeman P, Lee T, Wong CMC, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719
30. Snell LD, Johnson KM (1986) Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J Pharmacol Exp Ther 238:938-946
31. Snell LD, Morter RS, Johnson KM (1988) Structural requirements for activation of the glycine receptor that modulates the N-methyl-D-aspartate operated ion channel. Eur J Pharmacol 156:105-110
32. Sturgeon RD, Fessler RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59:169-179
33. Tanii Y, Nishikawa T, Hashimoto A, Takahashi K (1994) Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J Pharamacol Exp Ther 269:1040-1048
34. Toth E, Lajtha A (1986) Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochem Res 11:393-400
35. Welker WI (1962) An analysis of exploratory and play behavior in animals. In: Fiske DW, Maddi SR (eds) Functions of varied experience. Dorsey, Homewood, Ill., pp 175-226
36. Wong EHF, Kemp JA (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. In: Cho AK, Blaschke TF, Loh HH, Way JL (eds) Annual reviews of pharmacology and toxicology (vol 31). Annual Reviews Inc., Palo Alto, pp 401-425
37. Wu JC, Buchsbaum MS, Bunney WE (1989) PET scan study of patients on phencyclidine. Soc Neurosci Abstr 15:448(179.10)
38. Wu JC, Buchsbaum MS, Bunney WE (1991) Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. Jpn J Psychopharmacol 11:47-48